These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10695033)

  • 21. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
    Knable MB; Hyde TM; Herman MM; Carter JM; Bigelow L; Kleinman JE
    Biol Psychiatry; 1994 Dec; 36(12):827-35. PubMed ID: 7893846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics.
    Joyce JN; Gurevich EV
    Ann N Y Acad Sci; 1999 Jun; 877():595-613. PubMed ID: 10415673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
    Nordström AL; Farde L; Eriksson L; Halldin C
    Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
    Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
    Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
    Hietala J; Syvälahti E; Vilkman H; Vuorio K; Räkköläinen V; Bergman J; Haaparanta M; Solin O; Kuoppamäki M; Eronen E; Ruotsalainen U; Salokangas RK
    Schizophr Res; 1999 Jan; 35(1):41-50. PubMed ID: 9988840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of striatal dopamine D
    Veselinović T; Vernaleken I; Janouschek H; Cumming P; Paulzen M; Mottaghy FM; Gründer G
    Psychopharmacology (Berl); 2018 Aug; 235(8):2221-2232. PubMed ID: 29717334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
    Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
    Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central D2 receptors and negative symptoms of schizophrenia.
    Martinot JL; Paillère-Martinot ML; Loc'h C; Lecrubier Y; Dao-Castellana MH; Aubin F; Allilaire JF; Mazoyer B; Mazière B; Syrota A
    Br J Psychiatry; 1994 Jan; 164(1):27-34. PubMed ID: 8137107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schizophrenia: a computational reinforcement learning perspective.
    Frank MJ
    Schizophr Bull; 2008 Nov; 34(6):1008-11. PubMed ID: 18791075
    [No Abstract]   [Full Text] [Related]  

  • 36. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal D(2) dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study.
    Syvälahti EK; Räkköläinen V; Aaltonen J; Lehtinen V; Hietala J
    Schizophr Res; 2000 Jun; 43(2-3):159-61. PubMed ID: 10858634
    [No Abstract]   [Full Text] [Related]  

  • 40. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
    Shim JC; You YS; Kelly DL
    J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.